Kristina Brooks

Assistant Professor

University of Colorado Anschutz Medical Campus

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Brookie M. Best

University of California, San Diego

UNITED STATES

View details

Jose Castillo-Mancilla

Associate Professor of Medicine

University of Colorado School of Medicine

UNITED STATES

View details

Lisa Rohan

University of Pittsburgh

UNITED STATES

View details

Emily Barr

Assistant Professor

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kristina Brooks

Research Interests

Explore related searches

Contact this professor

Articles (15)

Antiretrovirals for Human Immunodeficiency Virus Treatment and Prevention in Pregnancy

Improving the accuracy of adherence data collected using medication monitoring technology in clinical research

Physiologically-based pharmacokinetic modeling of remdesivir and its metabolites in pregnant women with COVID-19

Intracellular Islatravir-Triphosphate in Dried Blood Spots and Peripheral Blood Mononuclear Cells from Pig-Tailed Macaques

Translating Clinical Pharmacology Data in Pregnancy to Evidence‐Based Guideline Recommendations: Perspectives From the HIV Field

Development and validation of an LC-MS/MS method to quantify the alcohol biomarker phosphatidylethanol 16:0/18:1 in dried blood spots for clinical research purposes

Pharmacokinetics, Safety, and Tolerability of Once-Daily Darunavir with Cobicistat and Weekly Isoniazid/Rifapentine

Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1–2 dose-confirmation study

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones.

Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate.

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s.

Pharmacokinetics of Tenofovir Alafenamide with Boosted Protease Inhibitors in Pregnant and Postpartum Women Living with HIV: Results from IMPAACT P1026s

Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use.

Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate.

Collaborators (4)

Brookie M. Best

Jose Castillo-Mancilla

Lisa Rohan

Emily Barr

Make your next move.